F-18 Florastamin

N/A

Report date: 2025/11/25 15:53:30
NME

Base Information

Drug NameF-18 Florastamin
Drug Alias Name18F-FC303氟[18F]司他明[18F]FLORFC-303
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionRadionuclide imaging enhancersPositron-emission tomography enhancers
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesFuturechem
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFuturechemHta Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A